These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35244020)

  • 21. Editorial: COVID-19 and Multisystem Inflammatory Syndrome in Children (MIS-C).
    Parums DV
    Med Sci Monit; 2021 May; 27():e933369. PubMed ID: 34075014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors Associated With Severe Gastrointestinal Diagnoses in Children With SARS-CoV-2 Infection or Multisystem Inflammatory Syndrome.
    Lo Vecchio A; Garazzino S; Smarrazzo A; Venturini E; Poeta M; Berlese P; Denina M; Meini A; Bosis S; Galli L; Cazzato S; Nicolini G; Vergine G; Giacchero R; Ballardini G; Dodi I; Salvini FM; Manzoni P; Ferrante G; Quadri V; Campana A; Badolato R; Villani A; Guarino A; Gattinara GC;
    JAMA Netw Open; 2021 Dec; 4(12):e2139974. PubMed ID: 34928354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 Without Recurrence of Multisystem Inflammatory Syndrome in Children.
    Buddingh EP; Vossen ACTM; Lamb HJ; van der Palen RLF; Brinkman DMC
    Pediatr Infect Dis J; 2021 Dec; 40(12):e491-e492. PubMed ID: 34382616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucocutaneous disease and related clinical characteristics in hospitalized children and adolescents with COVID-19 and multisystem inflammatory syndrome in children.
    Rekhtman S; Tannenbaum R; Strunk A; Birabaharan M; Wright S; Garg A
    J Am Acad Dermatol; 2021 Feb; 84(2):408-414. PubMed ID: 33323343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-inflammatory Syndrome in Children Related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Spain.
    Moraleda C; Serna-Pascual M; Soriano-Arandes A; Simó S; Epalza C; Santos M; Grasa C; Rodríguez M; Soto B; Gallego N; Ruiz Y; Urretavizcaya-Martínez M; Pareja M; Sanz-Santaeufemia FJ; Fumadó V; Lanaspa M; Jordan I; Prieto L; Belda S; Toral-Vázquez B; Rincón E; Gil-Villanueva N; Méndez-Echevarría A; Castillo-Serrano A; Rivière JG; Soler-Palacín P; Rojo P; Tagarro A;
    Clin Infect Dis; 2021 May; 72(9):e397-e401. PubMed ID: 32710613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multisystem inflammatory syndrome in children and SARS-CoV-2: A scoping review.
    Panigrahy N; Policarpio J; Ramanathan R
    J Pediatr Rehabil Med; 2020; 13(3):301-316. PubMed ID: 33252101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical-laboratory profile of children and adolescents with multisystem inflammatory syndrome temporarily associated with COVID-19 in Goiás, Brazil.
    da Costa MA; de Almeida RPA; Pondé RAA
    Arch Virol; 2023 Apr; 168(5):142. PubMed ID: 37067652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dermatological Manifestations of COVID-19 in Children.
    Panda M; Agarwal A; Hassanandani T
    Indian Pediatr; 2022 May; 59(5):393-399. PubMed ID: 35273132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comorbidities in Children with COVID-19 and MIS-C/PIMS-TS and Risk Factors for Hospitalization, Severe Disease, Intensive Care and Death.
    Ankermann T; Brinkmann F
    Klin Padiatr; 2022 Sep; 234(5):257-266. PubMed ID: 35114705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment of a pediatric COVID-19 biorepository: unique considerations and opportunities for studying the impact of the COVID-19 pandemic on children.
    Lima R; Gootkind EF; De la Flor D; Yockey LJ; Bordt EA; D'Avino P; Ning S; Heath K; Harding K; Zois J; Park G; Hardcastle M; Grinke KA; Grimmel S; Davidson SP; Forde PJ; Hall KE; Neilan AM; Matute JD; Lerou PH; Fasano A; Shui JE; Edlow AG; Yonker LM
    BMC Med Res Methodol; 2020 Sep; 20(1):228. PubMed ID: 32917141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limited induction of SARS-CoV-2-specific T cell responses in children with multisystem inflammatory syndrome compared with COVID-19.
    Singh V; Obregon-Perko V; Lapp SA; Horner AM; Brooks A; Macoy L; Hussaini L; Lu A; Gibson T; Silvestri G; Grifoni A; Weiskopf D; Sette A; Anderson EJ; Rostad CA; Chahroudi A
    JCI Insight; 2022 Feb; 7(4):. PubMed ID: 35044955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From asymptomatic to critical illness - different clinical manifestations of COVID-19 in children.
    Tezer H; Deniz M
    Turk J Med Sci; 2021 Dec; 51(SI-1):3262-3272. PubMed ID: 34392672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "For COVID" or "With COVID": Classification of SARS-CoV-2 Hospitalizations in Children.
    Kushner LE; Schroeder AR; Kim J; Mathew R
    Hosp Pediatr; 2021 Aug; 11(8):e151-e156. PubMed ID: 34011566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar.
    Tang P; Hasan MR; Chemaitelly H; Yassine HM; Benslimane FM; Al Khatib HA; AlMukdad S; Coyle P; Ayoub HH; Al Kanaani Z; Al Kuwari E; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul Rahim HF; Nasrallah GK; Al Kuwari MG; Al Romaihi HE; Butt AA; Al-Thani MH; Al Khal A; Bertollini R; Abu-Raddad LJ
    Nat Med; 2021 Dec; 27(12):2136-2143. PubMed ID: 34728831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Children and Adolescents With SARS-CoV-2 Infection: Epidemiology, Clinical Course and Viral Loads.
    Maltezou HC; Magaziotou I; Dedoukou X; Eleftheriou E; Raftopoulos V; Michos A; Lourida A; Panopoulou M; Stamoulis K; Papaevangelou V; Petinaki E; Mentis A; Papa A; Tsakris A; Roilides E; Syrogiannopoulos GA; Tsolia M;
    Pediatr Infect Dis J; 2020 Dec; 39(12):e388-e392. PubMed ID: 33031141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Children with a History of Multisystem Inflammatory Syndrome in Children: An International Survey.
    Hoste L; ; Soriano-Arandes A; Buddingh EP; Whittaker E; Belot A; Ulloa-Gutierrez R; Olbrich P; Haerynck F
    J Pediatr; 2022 Sep; 248():114-118. PubMed ID: 35598642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 in Children: Where do we Stand?
    Nikolopoulou GB; Maltezou HC
    Arch Med Res; 2022 Jan; 53(1):1-8. PubMed ID: 34311990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2.
    Diorio C; Henrickson SE; Vella LA; McNerney KO; Chase J; Burudpakdee C; Lee JH; Jasen C; Balamuth F; Barrett DM; Banwell BL; Bernt KM; Blatz AM; Chiotos K; Fisher BT; Fitzgerald JC; Gerber JS; Gollomp K; Gray C; Grupp SA; Harris RM; Kilbaugh TJ; John ARO; Lambert M; Liebling EJ; Paessler ME; Petrosa W; Phillips C; Reilly AF; Romberg ND; Seif A; Sesok-Pizzini DA; Sullivan KE; Vardaro J; Behrens EM; Teachey DT; Bassiri H
    J Clin Invest; 2020 Nov; 130(11):5967-5975. PubMed ID: 32730233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Multisystem inflammatory syndrome in children and adolescents after infection with SARS-CoV-2].
    Hu Y; Rojahn AE; Flatø B
    Tidsskr Nor Laegeforen; 2021 Oct; 141(2021-14):. PubMed ID: 34641663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study.
    Lindan CE; Mankad K; Ram D; Kociolek LK; Silvera VM; Boddaert N; Stivaros SM; Palasis S;
    Lancet Child Adolesc Health; 2021 Mar; 5(3):167-177. PubMed ID: 33338439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.